Synteni Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $72.9M
Latest Deal Amount

Synteni General Information

Description

Developer of genomics microarrays technology. The company has developed Gene Expression Microarray (GEM) which consists of up to ten thousand genes densely arrayed on a glass surface. GEM arrays are capable of analyzing thousands of genes in a single experiment by probing with fluorescently tagged DNA or RNA from a biological sample.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Palo Alto, CA 94306
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synteni Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Jan-1998 $72.9M 000.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Synteni’s complete valuation and funding history, request access »

Synteni Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
Shalon Ventures Venture Capital Minority 000 0000 000000 0
To view Synteni’s complete investors history, request access »